Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In
- PMID: 3701060
Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In
Abstract
A normal plasma lipoprotein, termed LDL-In, has been shown to be a potent inhibitor of mitogen-driven human lymphocyte proliferation in vitro and of primary antibody responses in the mouse. To determine whether the immunoregulatory activity of LDL-In resided with the protein rather than the lipid constituents of LDL-In, one of the apoproteins of LDL-In, apoprotein E, was isolated from plasma and was analyzed for its inhibitory activity. Apoprotein E, isolated after delipidization of lipoproteins with either methyl ethyl ketone or ethanol and ethyl ether, was immunosuppressive. Furthermore, the characteristics of inhibition of cellular [3H]thymidine uptake by isolated apoprotein E were identical to those characteristics obtained with suppression by LDL-In. Inhibition by apoprotein E and LDL-In required preincubation of the cells with either apoprotein or lipoprotein for 24 hr before exposure of the cells to mitogen for maximal expression of suppressive activity, and this inhibition could not be reversed by removal of non-cell-associated inhibitor before stimulation. Neither apoprotein E or LDL-In was inhibitory when they were added to the cells after mitogen stimulation. The only difference noted between suppression by apoprotein E and LDL-In was that of dose. Compared with quantitative estimates of the apoprotein E content of LDL-In, significantly more isolated apoprotein E was required than lipoprotein-associated E for comparable levels of suppression. The potency of apoprotein E could be increased by adding it to cells in the presence of dimyristoylphosphatidylcholine/cholesterol vesicles. The data suggesting that phospholipid increased the specific activity of apoprotein E by altering its molecular dispersion was obtained from analyses of the interaction of apo E with cells, as well as the plastic culture vessels. The results suggested that the molecular dispersion and perhaps organization of isolated apoprotein E in an aqueous system is critical to its interaction with lymphocytes and subsequently its biological activity.
Similar articles
-
Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In.J Immunol. 1980 Oct;125(4):1470-4. J Immunol. 1980. PMID: 7410845
-
Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.J Immunol. 1984 Sep;133(3):1379-84. J Immunol. 1984. PMID: 6430997
-
The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content.J Immunol. 1981 Apr;126(4):1382-6. J Immunol. 1981. PMID: 7204969
-
Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.Biochemistry. 1997 Oct 21;36(42):12766-72. doi: 10.1021/bi9631024. Biochemistry. 1997. PMID: 9335533
-
Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).Kidney Int Suppl. 1997 Dec;63:S102-6. Kidney Int Suppl. 1997. PMID: 9407434 Review.
Cited by
-
The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.J Biomed Biotechnol. 2010;2010:357412. doi: 10.1155/2010/357412. Epub 2010 Feb 16. J Biomed Biotechnol. 2010. PMID: 20182542 Free PMC article. Review.
-
Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Clin Microbiol Rev. 2003 Jul;16(3):379-414. doi: 10.1128/CMR.16.3.379-414.2003. Clin Microbiol Rev. 2003. PMID: 12857774 Free PMC article. Review.
-
Apolipoprotein E isoforms increase intracellular Ca2+ differentially through a omega-agatoxin IVa-sensitive Ca2+-channel.Brain Pathol. 1998 Oct;8(4):641-53. doi: 10.1111/j.1750-3639.1998.tb00190.x. Brain Pathol. 1998. PMID: 9804373 Free PMC article.
-
Mechanisms of cerebral injury from cardiac surgery.Crit Care Clin. 2008 Jan;24(1):83-98, viii-ix. doi: 10.1016/j.ccc.2007.09.004. Crit Care Clin. 2008. PMID: 18241780 Free PMC article. Review.
-
MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2813-9. doi: 10.1161/ATVBAHA.111.238642. Epub 2011 Sep 29. Arterioscler Thromb Vasc Biol. 2011. PMID: 21960563 Free PMC article.